查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1981347

骨水泥及黏合剂市场：全球市场按产品类型、技术、应用、最终用户和分销管道分類的预测 - 2026-2032年

Bone Cement & Glue Market by Product Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，骨水泥和黏合剂市场价值将达到 21.1 亿美元，到 2026 年将成长到 22.5 亿美元，到 2032 年将达到 32.9 亿美元，复合年增长率为 6.58%。

主要市场统计数据
基准年 2025 21.1亿美元
预计年份：2026年 22.5亿美元
预测年份 2032 32.9亿美元
复合年增长率 (%) 6.58%

本介绍部分清楚地说明了生物材料的创新和临床工作流程的进步如何重新定义骨水泥和外科黏合剂的选择。

随着生物材料技术的进步与外科手术流程的不断演进，骨水泥和黏合剂领域正吸引临床、监管和商业相关人员的广泛关注。本报告首先概述了骨水泥和黏合剂在现代整形外科、颅颜外科、口腔外科和脊椎外科治疗流程中的作用，然后阐述了成分、剂型和最终用户环境的差异如何影响其应用和临床疗效。

生物材料的进步、手术流程向门诊转移以及更严格的监管要求，正在如何改变市场动态和临床应用？

过去几年，在材料科学的突破、手术流程的改进以及监管力度的加强的推动下，骨水泥和外科黏合剂的竞争格局和临床环境发生了翻天覆地的变化。生物活性配方的创新已从概念验证发展到常规临床评估阶段，从而实现了能够促进骨整合并提供可控吸收特性的材料。同时，注射剂和可塑形剂等给药机制的改进，也扩大了这些产品在微创手术和门诊手术的应用范围。

我们将评估近期关税措施如何促使各产业进行策略供应链重组、采购地理多元化和商业合约转型。

2025年关税的实施和贸易政策的变化，为骨水泥和骨接合剂产业的供应链策略带来了显着的转捩点。中间体和成品的进口关税增加了依赖跨境生产聚合物、活性添加剂和包装材料的製造商的接收成本。为此，各公司正在重新审视筹资策略，并加速生产能力的地域多角化，以降低关税波动带来的风险，确保及时向关键临床客户交付产品。

详细的細項分析揭示了产品化学特性、临床应用、最终用户环境、技术类型和分销管道如何形成差异化的进入管道。

细分市场分析揭示了产品的细微性能特征和分销管道差异，这些差异取决于产品的化学性质、临床应用、终端用户环境、技术分类和分销模式。按产品类型划分，市场包括丙烯酸骨水泥和磷酸钙骨水泥。丙烯酸骨水泥可进一步细分为用于感染控制通讯协定的含抗生素配方和用于标准固定需求的不含抗生素配方。另一方面，磷酸钙骨水泥则以注射型和可塑型两种形式提供，以满足微创给药和术中塑形的需求。

美洲、欧洲、中东和非洲以及亚太地区的趋势将影响采用率、监管重点和供应策略。

区域趋势对商业化策略和产品开发重点均有显着影响。在美洲，成熟的医院基础设施、广泛的私立医院网络以及不断扩大的门诊手术能力正在塑造市场需求趋势，为现有的基于聚甲基丙烯酸甲酯（PMMA）的产品以及新兴的、用于控制感染和促进骨整合的生物活性配方创造了机会。该地区完善的采购流程有助于建立长期的供应商关係和系统化的合约机制，这些机制重视实证绩效和可靠的供应链。

竞争格局概述，展示了成熟企业、专业创新者和通路伙伴如何塑造其产品差异化和打入市场策略。

骨水泥和外科黏合剂领域的竞争动态由成熟製造商、专业生医材料公司、契约製造以及专注于下一代生物活化技术的创新Start-Ups共同构成。成熟企业受益于与大规模医院系统的紧密合作关係、广泛的企业发展以及在多个司法管辖区获得监管核准的经验。这些成熟企业通常利用规模经济来优化生产成本，投资于临床证据的开发，并提供包含仪器和培训在内的成套解决方案。

在不断变化的医疗保健环境中，製造商和供应商需要采取具体的策略重点来增强临床差异化、供应韧性和商业性扩充性。

骨水泥和黏合剂产业的领导企业应采取多管齐下的策略，以提升产品卓越性、增强供应链韧性并适应不断变化的临床路径。首先，应投资于临床证据项目，以产生真实世界的结果数据，证明其不仅符合监管要求，还能降低感染率、提高植入稳定性并缩短患者康復时间。这些数据有助于在采购谈判中提出差异化的价值提案，并有助于将产品纳入医院处方集和优选供应商名单。

为了确保实践的严谨性，我们采用了稳健的混合方法研究途径，结合了对临床医生的访谈、对供应商的文件分析以及多方面的数据匹配。

本分析所依据的研究融合了定性和定量方法，以确保获得全面且基于证据的见解。主要研究包括对整形外科、颅颜外科和牙科的临床医生、医院和门诊手术中心的采购经理、生物材料製造商的产品经理以及分销商的高阶主管进行结构化访谈。这些访谈直接揭示了影响产品选择的临床绩效预期、采购决策者以及营运限制因素。

策略概述重点在于临床表现、采购重点和供应弹性之间的整合，这将决定未来的市场领导。

总之，骨水泥和外科黏合剂市场正朝着兼具可靠的机械性能、生物活性和在各种手术环境中易于操作的解决方案方向发展。这项转变的驱动力来自临床对改善治疗效果的需求、采购压力对价值和供应韧性的重视，以及监管机构对病人安全和实证实践的优先考虑。那些将产品开发与临床工作流程相结合，并投资于扩充性且具有区域弹性的供应模式的相关人员，将更有利于把握新的机会。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 骨水泥和黏合剂市场：依产品类型划分

  • 丙烯酸骨水泥
    • 抗生素组合
    • 不含抗生素
  • 磷酸钙水泥
    • 射出模具
    • 可塑性

第九章 骨水泥和黏合剂市场：依技术划分

  • 生物活性
    • 磷酸钙
    • 硅酸钙
  • PMMA型
    • 高黏度
    • 低黏度

第十章 骨水泥与黏合剂市场：依应用领域划分

  • 颅颚颜面
    • 重组手术
    • 创伤修復
  • 牙科
    • 植入
    • 维修
  • 整形外科
    • 骨折固定
    • 关节重建手术
    • 脊椎手术

第十一章 骨水泥与黏合剂市场：依最终用户划分

  • 门诊手术中心
    • 多学科部门
    • 整形外科中心
  • 医院
    • 私立医院
    • 公立医院
  • 专科诊所
    • 牙医诊所
    • 门诊復健

第十二章 骨水泥与黏合剂市场：依通路划分

  • 直销
    • OEM合作伙伴关係
    • 竞标和合约
  • 销售代理
    • 集团采购组织
    • 独立销售代理
  • 线上管道
    • 电子商务平台
    • 製造商网站

第十三章 骨水泥和黏合剂市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 骨水泥与黏合剂市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 骨水泥和黏合剂市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国骨水泥与黏合剂市场

第十七章：中国骨水泥和黏合剂市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • B. Braun Melsungen AG
  • DePuy Synthes, Inc.
  • DJO Global, Inc.
  • Heraeus Medical GmbH
  • Medtronic plc
  • Paragon 28, LLC
  • Smith & Nephew plc
  • Stryker Corporation
  • TEI Biosciences, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-521BAA36EADE

The Bone Cement & Glue Market was valued at USD 2.11 billion in 2025 and is projected to grow to USD 2.25 billion in 2026, with a CAGR of 6.58%, reaching USD 3.29 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.11 billion
Estimated Year [2026] USD 2.25 billion
Forecast Year [2032] USD 3.29 billion
CAGR (%) 6.58%

A clarifying introduction to how biomaterial innovation and clinical workflow evolution are redefining bone cement and surgical adhesive selection

The bone cement and adhesive landscape is experiencing heightened attention from clinical, regulatory, and commercial stakeholders as advances in biomaterials converge with evolving surgical workflows. This report opens with an oriented introduction that situates bone cement and glue within contemporary orthopedic, craniofacial, dental, and spinal care pathways, clarifying how variations in composition, delivery formats, and end-user settings influence adoption and clinical outcomes.

Clinical teams increasingly demand materials that balance handling characteristics with biological performance. Consequently, the sector's product mix now spans traditional polymethyl methacrylate (PMMA)-based cements and newer bioactive chemistries designed to support tissue integration or deliver localized therapeutics. Meanwhile, distribution and procurement models are being reshaped by the rise of group purchasing organizations, tender-driven hospital contracts, and direct manufacturer relationships that prioritize long-term value and supply resilience.

From a buyer's perspective, technology selection is influenced by procedural complexity, setting capabilities, and reimbursement dynamics, leading to differentiated uptake across hospital operating rooms, ambulatory surgical centers, and specialty clinics. As a result, stakeholders must evaluate product portfolios not only on primary performance metrics but also on sterilization, storage, and in-procedure workflow compatibility. This introduction frames those dynamics and sets expectations for the deeper analysis to follow.

How advances in biomaterials, procedural migration to outpatient settings, and elevated regulatory requirements are reshaping market dynamics and clinical adoption

Over the past several years, transformative shifts have altered both the competitive and clinical landscapes for bone cements and surgical glues, driven by material science breakthroughs, procedural migration, and heightened regulatory scrutiny. Innovations in bioactive formulations have advanced from proof-of-concept to routine clinical evaluation, enabling materials that promote osteointegration and provide controlled resorption profiles. At the same time, improvements in delivery mechanisms, such as injectable and moldable formats, have expanded the range of minimally invasive and outpatient procedures that can reliably utilize these products.

Concurrently, there has been a steady movement of select procedures from inpatient settings to ambulatory surgical centers and specialty clinics, prompted by cost containment pressures and the drive to reduce hospital length of stay. This migration has pushed suppliers to refine packaging, sterilization, and handling features to suit lower-acuity settings where space and instrumentation differ from traditional OR environments. Transitioning procedural venues has also highlighted the importance of product ease-of-use and predictable performance under constrained time windows.

Regulatory expectations have intensified, particularly around safety labeling for antibiotic-loaded products and clinical data supporting long-term outcomes. As a result, companies are investing more heavily in clinical evidence generation and post-market surveillance. These combined shifts - material innovation, procedural migration, and regulatory focus - are creating new avenues for competitive differentiation while raising the bar for market entry and sustained commercial success.

Assessing how recent tariff measures have prompted strategic supply chain reconfiguration, sourcing regionalization, and commercial contracting shifts across the sector

The introduction of tariffs and trade policy changes in 2025 has created a measurable inflection point for supply chain strategies across the bone cement and glue sector. Import duties on intermediate inputs and finished devices have increased landed costs for manufacturers that rely on cross-border production of polymers, active additives, and packaging materials. In response, firms are reassessing sourcing strategies while accelerating regionalization of manufacturing capacity to reduce exposure to tariff volatility and to safeguard delivery timelines to key clinical customers.

As procurement teams adapt to higher input costs, there is stronger emphasis on value-based contracting and longer-term supply agreements that lock in pricing and service levels. This has intensified negotiations with distributors and group purchasing organizations, which are themselves recalibrating supplier portfolios to prioritize manufacturers with secure, near-shore production footprints. Consequently, companies without diversified manufacturing nodes or those dependent on single-source suppliers are under pressure to either secure alternative suppliers or to invest in localized production capabilities.

The tariff environment has also catalyzed innovation in packaging and product design to optimize transport efficiency and reduce weight- or volume-based duties. In parallel, firms are increasingly exploring toll manufacturing and licensing arrangements with regional partners to maintain market continuity while bypassing certain trade barriers. These strategic responses are not only tactical cost mitigations but also long-term decisions that influence competitive positioning, time-to-market for new formulations, and the resilience of supply chains amid shifting trade policies.

In-depth segmentation analysis reveals how product chemistry, clinical application, end-user settings, technology types, and distribution choices drive differentiated adoption pathways

Segmentation analysis reveals nuanced performance characteristics and adoption pathways that vary by product chemistry, clinical application, end-user setting, technology class, and distribution model. In terms of product type, the market encompasses acrylic bone cement and calcium phosphate cement; the acrylic segment is distinguished by antibiotic-loaded formulations and non-antibiotic variants that cater to infection control protocols and standard fixation needs respectively, while calcium phosphate alternatives are offered in injectable and moldable forms that respond to preferences for minimally invasive delivery or intraoperative shaping.

When viewed through the lens of application, clinical demand is distributed across craniomaxillofacial, dental, and orthopedic specialties. Craniomaxillofacial indications focus on reconstructive surgery and trauma repair with an emphasis on contour restoration and fixation; dental applications span implantology and restorative procedures where biocompatibility and handling impact osseointegration; orthopedic uses cover fracture fixation, joint replacement, and spinal surgery, each with distinct mechanical and biological performance imperatives that inform material selection.

End-user differentiation is significant: ambulatory surgical centers-comprising multi-specialty and orthopedic centers-prioritize quick-setting, easy-to-handle systems that align with accelerated throughput, whereas hospitals, both private and public institutions, demand versatility across complex procedures and compatibility with institutional purchasing protocols. Specialty clinics, including dental clinics and outpatient rehabilitation centers, require smaller package formats and user-friendly delivery systems tailored to high-volume, outpatient workflows.

Technology segmentation separates bioactive approaches from PMMA-based platforms. Bioactive technologies include calcium phosphate and calcium silicate variants designed to interact with host tissue and promote healing, while PMMA-based solutions present high-viscosity and low-viscosity options chosen for their mechanical stability and handling characteristics. From a distribution perspective, direct sales arrangements-built on OEM relationships and tender contracts-favor large institutional customers, distributors operate through group purchasing organizations and independent channels to reach a broader base, and online channels, comprising e-commerce platforms and manufacturer websites, are increasingly important for small-volume purchasers and quick replenishment. Together, these segmentation axes create a matrix of demand signals that manufacturers and suppliers must decode to align product development, marketing, and sales strategies effectively.

Regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific that influence adoption, regulatory priorities, and supply strategies

Regional dynamics materially influence both commercialization strategies and product development priorities. In the Americas, demand trends are shaped by a mature hospital infrastructure, expansive private hospital networks, and growing outpatient surgical capacity, which together create opportunities for both established PMMA-based products and emerging bioactive formulations that address infection control and osteointegration. The region's procurement sophistication encourages long-term supplier relationships and structured contracting mechanisms that reward evidence-backed performance and reliable supply chains.

In Europe, Middle East & Africa, regulatory harmonization and diverse healthcare models create a complex mosaic of adoption curves. Western European markets demand rigorous clinical data and often serve as launchpads for advanced bioactive materials, while markets in other parts of the region may emphasize cost-effectiveness and supply chain adaptability. Emerging markets within this region present growth potential driven by infrastructure investment and expanding access to surgical care, yet they require tailored distribution approaches and flexible pricing structures.

The Asia-Pacific region is characterized by a broad spectrum of market maturity, with high-volume centers in urban hubs adopting sophisticated materials and delivery systems, and peripheral settings prioritizing affordability and ease of use. Local manufacturing hubs and a thriving medtech innovation ecosystem in several countries are accelerating product localization and customization. Across all regions, supply chain resilience, regulatory alignment, and the ability to demonstrate clinical and economic value remain decisive factors for sustained adoption and market penetration.

Competitive landscape overview showing how incumbents, specialized innovators, and channel partners shape product differentiation and market access strategies

Competitive dynamics in the bone cement and surgical glue ecosystem are defined by a mixture of legacy manufacturers, specialty biomaterials firms, contract manufacturers, and innovative startups focused on next-generation bioactive chemistries. Established players benefit from entrenched relationships with large hospital systems, extensive commercial footprints, and experience with regulatory approvals across multiple jurisdictions. These incumbents often leverage scale to optimize manufacturing costs, invest in clinical evidence development, and offer bundled solutions that include instrumentation and training.

At the same time, midsized and emerging firms are differentiating through focused investments in niche technologies such as antibiotic-loaded cements with refined elution profiles, calcium phosphate systems designed for specific orthopedic niches, and high-precision delivery platforms that reduce intraoperative variability. Contract manufacturing organizations play an increasingly strategic role by enabling smaller innovators to scale production while managing quality systems and regulatory compliance.

Distribution partners, including national distributors and group purchasing organizations, act as gatekeepers to hospital formularies and ambulatory networks; their influence over purchasing decisions underscores the importance of channel strategies that balance direct sales relationships with broader distribution agreements. Partnerships and licensing arrangements are common as faster time-to-market and local regulatory alignment become priorities. Overall, competitive success hinges on a company's ability to demonstrate clinical differentiation, maintain supply continuity, and engage with stakeholders across procurement, clinical practice, and hospital leadership.

Actionable strategic priorities for manufacturers and suppliers to strengthen clinical differentiation, supply resilience, and commercial scalability in evolving care settings

Leaders in the bone cement and glue sector should adopt a multi-pronged strategy that addresses product excellence, supply chain resilience, and alignment with evolving clinical pathways. First, invest in clinical evidence programs that not only meet regulatory requirements but also generate real-world outcomes data demonstrating improvements in infection rates, implant stability, and patient recovery timelines. Such data supports differentiated value propositions during procurement negotiations and facilitates placement on hospital formularies and preferred vendor lists.

Second, diversify manufacturing and sourcing footprints to mitigate trade policy exposures and to ensure continuity of supply for critical hospital customers. This may include pursuing regional manufacturing partnerships, tolling agreements, or selective near-shoring to reduce lead times and tariff impacts. In tandem, optimize packaging and logistics to minimize transport costs and to meet the specific needs of ambulatory and outpatient settings where space and instrumentation differ from traditional operating theaters.

Third, refine commercial models to balance direct sales with distributor partnerships and digital channels. Direct engagement with large institutional buyers remains important for complex offerings, while distributors and online platforms can extend reach into smaller clinics and dental practices. Additionally, prioritize training and education programs that simplify product handling and demonstrate procedural efficiencies; clinicians value hands-on support and evidence-backed protocols that reduce intraoperative uncertainty.

Finally, pursue targeted R&D focused on user-centric product features such as adjustable setting times, improved radiopacity, and compatible delivery tools. Complement product development with strategic collaborations that accelerate clinical validation and regulatory approvals. Taken together, these actions will strengthen market positioning and create durable competitive advantage as clinical and procurement landscapes continue to evolve.

Robust mixed-methods research approach combining clinician interviews, supplier documentation analysis, and multi-source data triangulation to ensure actionable rigor

The research underpinning this analysis integrates qualitative and quantitative approaches to ensure comprehensive, evidence-based insights. Primary research consisted of structured interviews with clinicians across orthopedics, craniofacial surgery, and dentistry, procurement leaders from hospitals and ambulatory surgical centers, product managers from biomaterials companies, and distribution executives. These conversations provided direct perspectives on clinical performance expectations, procurement decision drivers, and operational constraints that shape product selection.

Secondary research involved systematic review of peer-reviewed literature, regulatory guidance documents, and publicly available clinical study summaries to validate material properties, performance claims, and safety profiles. In addition, supplier documentation, product IFUs, and clinical technique guides were analyzed to assess handling characteristics and usage protocols. Data triangulation combined insights from primary interviews with secondary sources to identify convergent themes and to reconcile conflicting viewpoints.

Analytical techniques included thematic coding of qualitative transcripts, comparative feature mapping across product types and technologies, and scenario analysis to evaluate the impact of supply chain disruptions and policy shifts. Quality assurance steps encompassed cross-validation with multiple interviewees, peer review of draft findings by subject matter experts, and adherence to transparent documentation standards for data sources and methodological assumptions. This robust methodology ensures the findings offer both practical relevance and analytical rigor for stakeholders seeking to inform strategy and operational planning.

Strategic closing perspective highlighting the convergence of clinical performance, procurement priorities, and supply resilience that will determine future market leaders

In closing, the bone cement and surgical adhesive market is transitioning toward solutions that blend reliable mechanical performance with biological activity and practical handling for diverse procedural settings. This evolution is driven by clinical demand for improved outcomes, by procurement pressures that emphasize value and supply resilience, and by regulatory expectations that prioritize patient safety and evidence-based practice. Stakeholders that align product development with clinical workflows and that invest in scalable, regionally resilient supply models will be best positioned to capture emerging opportunities.

As the sector advances, success will increasingly depend on the ability to translate material science into executable clinical advantages-reducing infection risk, enhancing fixation, and improving patient recovery-while simultaneously navigating the complexities of distribution and procurement. Collaborative approaches that engage clinicians early in design, partner with regional manufacturers or contract manufacturers to secure supply, and employ data-driven value propositions will differentiate suppliers in a competitive landscape. Overall, the outlook favors those who can combine demonstrable clinical value with operational excellence and strategic agility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bone Cement & Glue Market, by Product Type

  • 8.1. Acrylic Bone Cement
    • 8.1.1. Antibiotic Loaded
    • 8.1.2. Non Antibiotic Loaded
  • 8.2. Calcium Phosphate Cement
    • 8.2.1. Injectable
    • 8.2.2. Moldable

9. Bone Cement & Glue Market, by Technology

  • 9.1. Bioactive
    • 9.1.1. Calcium Phosphate
    • 9.1.2. Calcium Silicate
  • 9.2. PMMA Based
    • 9.2.1. High Viscosity
    • 9.2.2. Low Viscosity

10. Bone Cement & Glue Market, by Application

  • 10.1. Craniomaxillofacial
    • 10.1.1. Reconstructive Surgery
    • 10.1.2. Trauma Repair
  • 10.2. Dental
    • 10.2.1. Implantology
    • 10.2.2. Restorative
  • 10.3. Orthopedic
    • 10.3.1. Fracture Fixation
    • 10.3.2. Joint Replacement
    • 10.3.3. Spinal Surgery

11. Bone Cement & Glue Market, by End User

  • 11.1. Ambulatory Surgical Centers
    • 11.1.1. Multi Specialty
    • 11.1.2. Orthopedic Centers
  • 11.2. Hospitals
    • 11.2.1. Private Hospital
    • 11.2.2. Public Hospital
  • 11.3. Specialty Clinics
    • 11.3.1. Dental Clinics
    • 11.3.2. Outpatient Rehab

12. Bone Cement & Glue Market, by Distribution Channel

  • 12.1. Direct Sales
    • 12.1.1. OEM Relationships
    • 12.1.2. Tender Contracts
  • 12.2. Distributors
    • 12.2.1. Group Purchasing Organizations
    • 12.2.2. Independent Distributors
  • 12.3. Online Channels
    • 12.3.1. E Commerce Platforms
    • 12.3.2. Manufacturer Website

13. Bone Cement & Glue Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bone Cement & Glue Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bone Cement & Glue Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Bone Cement & Glue Market

17. China Bone Cement & Glue Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. B. Braun Melsungen AG
  • 18.6. DePuy Synthes, Inc.
  • 18.7. DJO Global, Inc.
  • 18.8. Heraeus Medical GmbH
  • 18.9. Medtronic plc
  • 18.10. Paragon 28, LLC
  • 18.11. Smith & Nephew plc
  • 18.12. Stryker Corporation
  • 18.13. TEI Biosciences, Inc.
  • 18.14. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BONE CEMENT & GLUE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BONE CEMENT & GLUE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BONE CEMENT & GLUE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BONE CEMENT & GLUE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BONE CEMENT & GLUE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BONE CEMENT & GLUE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ANTIBIOTIC LOADED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY NON ANTIBIOTIC LOADED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MOLDABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM SILICATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HIGH VISCOSITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY LOW VISCOSITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TRAUMA REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY IMPLANTOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY RESTORATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MULTI SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OUTPATIENT REHAB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY OEM RELATIONSHIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY TENDER CONTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 293. GLOBAL BONE CEMENT & GLUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 294. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 295. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 297. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 298. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 299. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 300. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 301. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 302. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 303. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 304. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 305. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 307. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 308. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 309. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 310. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 311. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 312. ASEAN BONE CEMENT & GLUE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 313. GCC BONE CEMENT & GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 314. GCC BONE CEMENT & GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. GCC BONE CEMENT & GLUE MARKET SIZE, BY ACRYLIC BONE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 316. GCC BONE CEMENT & GLUE MARKET SIZE, BY CALCIUM PHOSPHATE CEMENT, 2018-2032 (USD MILLION)
  • TABLE 317. GCC BONE CEMENT & GLUE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 318. GCC BONE CEMENT & GLUE MARKET SIZE, BY BIOACTIVE, 2018-2032 (USD MILLION)
  • TABLE 319. GCC BONE CEMENT & GLUE MARKET SIZE, BY PMMA BASED, 2018-2032 (USD MILLION)
  • TABLE 320. GCC BONE CEMENT & GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 321. GCC BONE CEMENT & GLUE MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 322. GCC BONE CEMENT & GLUE MARKET SIZE, BY DENTAL, 2018-2032 (USD MILLION)
  • TABLE 323. GCC BONE CEMENT & GLUE MARKET SIZE, BY ORTHOPEDIC, 2018-2032 (USD MILLION)
  • TABLE 324. GCC BONE CEMENT & GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 325. GCC BONE CEMENT & GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 326. GCC BONE CEMENT & GLUE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 327. GCC BONE CEMENT & GLUE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 328. GCC BONE CEMENT & GLUE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 329. GCC BONE CEMENT & GLUE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)

TA